FDA lists BPC-157 among 503A Category-2 ingredients that present significant safety risks for traditional compounding
Each session includes sterile preparation, a brief wellness check in and a smooth, minimally invasive injection performed by trained clinicians
These figures are useful for purchasing decisions before starting
The FDA specifically warned about peptide-related impurities and API characterization problems in other words, that whats in the vial might not be 100% pure BPC-157, and even if it is, the peptide could degrade or contain variants
Both these molecules show promise in various therapeutic applications, but how do they stack up against each other
Book an NAD IV Therapy Treatment If you are interested in our NAD IV Therapy, please note this service is different from our other IV therapies and can take 3-4 hours